Hormonal therapy in carcinoma of the breast.I. Effect of oral progesterone on clinical course and metabolism of nitrogen and selected electrolytes and steroids
1960; Wiley; Volume: 13; Issue: 4 Linguagem: Inglês
10.1002/1097-0142(196007/08)13
ISSN1097-0142
AutoresHerbert Volk, George C. Escher, Robert A. Huseby, Frank H. Tyler, Jesus Cheda,
Tópico(s)Breast Lesions and Carcinomas
ResumoCancerVolume 13, Issue 4 p. 757-763 ArticleFree Access Hormonal therapy in carcinoma of the breast. I. Effect of oral progesterone on clinical course and metabolism of nitrogen and selected electrolytes and steroids Herbert Volk M.D., SC.D, Herbert Volk M.D., SC.D Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.Search for more papers by this authorGeorge C. Escher M.D., George C. Escher M.D. Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.Search for more papers by this authorRobert A. Huseby M.D., Robert A. Huseby M.D. Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.Search for more papers by this authorFrank H. Tyler M.D., Frank H. Tyler M.D. Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.Search for more papers by this authorJesus Cheda M.D., Jesus Cheda M.D. Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y. Trainee, National Cancer Institute, of the National Institutes of Health, Public Health Service, at the Albert Einstein College of Medicine of Yeshiva University, New York, N.Y.Search for more papers by this author Herbert Volk M.D., SC.D, Herbert Volk M.D., SC.D Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.Search for more papers by this authorGeorge C. Escher M.D., George C. Escher M.D. Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.Search for more papers by this authorRobert A. Huseby M.D., Robert A. Huseby M.D. Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.Search for more papers by this authorFrank H. Tyler M.D., Frank H. Tyler M.D. Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.Search for more papers by this authorJesus Cheda M.D., Jesus Cheda M.D. Departments of Surgery, Albert Einstein College of Medicine of Yeshiva University, New York, N.Y., and the University of Colorado School of Medicine, Denver, Colo., the Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, and the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y. Trainee, National Cancer Institute, of the National Institutes of Health, Public Health Service, at the Albert Einstein College of Medicine of Yeshiva University, New York, N.Y.Search for more papers by this author First published: July/August 1960 https://doi.org/10.1002/1097-0142(196007/08)13:4 3.0.CO;2-9Citations: 11 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1. Albert, A.: Procedure for routine clinical determination of urinary gonadotropin. Proc. Staff Meet. Mayo Clin. 30: 552–555, 1955. CASPubMedWeb of Science®Google Scholar 2. Bonsnes, R. W., and Taussky, H. H.: On colorimetric determination of creatinine by Jaffe reaction. J. Biol. Chem. 158: 581–591, 1945. CASWeb of Science®Google Scholar 3. Callow, N. H.: Callow, R. K., and Emmens, C. W.: Colorimetric determination of substances containing grouping —CH2.CO— in urine extracts as indication of androgen content. Biochem. J. 32: 1312–1331, 1938. CASPubMedWeb of Science®Google Scholar 4. Eik-Nes, K.: Determination of 17 21-dihydroxy-20-ketosteroids in blood plasma. J. Clin. Endocrinol. 17: 502–511, 1957. 10.1210/jcem-17-4-502 CASPubMedWeb of Science®Google Scholar 5. Escher, G. C.: Personal communication. Google Scholar 6. Glenn, E. M., and Nelson, D. H.: Chemical method for determination of 17-hydroxycorticosteroids and 17-ketosteroids in urine following hydrolysis with β-glucuronidase. J. Clin. Endocrinol. 13: 911–920, 1953. 10.1210/jcem-13-8-911 CASPubMedWeb of Science®Google Scholar 7. Goldenberg, H.: Decantation as precision step in colorimetric analysis. Anal. Chem. 28: 1003–1006, 1956. 10.1021/ac60114a022 CASWeb of Science®Google Scholar 8. Gordon, D., Horwitt, B. N., Segaloff, A., Murison, P. J., and Schlosser, J. V.: Hormonal therapy in cancer of breast; III, effect of progesterone on clinical course and hormonal excretion. Cancer 5: 275–277, 1952. 10.1002/1097-0142(195203)5:2 3.0.CO;2-H CASPubMedWeb of Science®Google Scholar 9. Hanok, A.: Laboratory Manual of Clinical Chemistry. New York, N.Y. Albert Einstein College of Medicine. 1957. [Mimeo.] Google Scholar 10. Klinefelter, H. F., Jr., Albright, F., and Griswold, G. C.: Experience with quantitative test for normal or decreased amounts of follicle stimulating hormone in urine in endocrinological diagnosis. J. Clin. Endocrinol. 3: 529–544, 1943. 10.1210/jcem-3-10-529 CASGoogle Scholar 11. Kyle, L. H., and Hess, W. C.: Effect of progesterone and anhydrohydroxyprogesterone on nitrogen balance. J. Lab. & Clin. Med. 47: 278–283, 1956. CASPubMedWeb of Science®Google Scholar 12. Landau, R. L., Bergenstal, D. M., Lugibihl, K., and Kascht, M. E.: Metabolic effects of progesterone in man. J. Clin. Endocrinol. 15: 1194–1215, 1955. 10.1210/jcem-15-10-1194 CASPubMedWeb of Science®Google Scholar 13. Landau, R. L., Lugibihl, K., Bergenstal, D. M., and Dimick, D. F.: Metabolic effects of progesterone in man; dose response relationships. J. Lab. & Clin. Med. 50: 613–620, 1957. CASPubMedWeb of Science®Google Scholar 14. Perkoff, G. T., Eik-Nes, K., Nugent, C. A., Fred, H. L., Nimer, R. A., Rush, L., Samuels, L. T., and Tyler, F. H.: Studies of diurnal variation of plasma 17-hydroxycorticosteroids in man. J. Clin. Endocrinol. 19: 432–443, 1959. 10.1210/jcem-19-4-432 CASPubMedWeb of Science®Google Scholar 15. Taylor, S. G., III, and Morris, R. S., Jr.: Hormones in breast metastasis therapy. M. Clin. North America 35: 51–61, 1951. 10.1016/S0025-7125(16)35321-4 PubMedGoogle Scholar 16. Tyler, F. H., and Haskell, J.: Unpublished data. Google Scholar Citing Literature Volume13, Issue4July/August 1960Pages 757-763 ReferencesRelatedInformation
Referência(s)